AKT1 and colorectal cancer: Clinical and experimental studies have shown that PI3KCA mutations may play an important role in the development of microsatellite instability (MSI) colorectal cancer and regulation of the PI3K/Akt pathway can effectively inhibit PI3KCA mutations [32].